Surber B

References (4)

Title : [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors - Donnelly-Roberts_2009_Neuropharmacol_56_223
Author(s) : Donnelly-Roberts D , Namovic MT , Surber B , Vaidyanathan SX , Perez-Medrano A , Wang Y , Carroll WA , Jarvis MF
Ref : Neuropharmacology , 56 :223 , 2009
Abstract : Donnelly-Roberts_2009_Neuropharmacol_56_223
ESTHER : Donnelly-Roberts_2009_Neuropharmacol_56_223
PubMedSearch : Donnelly-Roberts_2009_Neuropharmacol_56_223
PubMedID: 18602931

Title : [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]hept ane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain - Anderson_2008_J.Pharmacol.Exp.Ther_324_179
Author(s) : Anderson DJ , Bunnelle W , Surber B , Du J , Surowy C , Tribollet E , Marguerat A , Bertrand D , Gopalakrishnan M
Ref : Journal of Pharmacology & Experimental Therapeutics , 324 :179 , 2008
Abstract : Anderson_2008_J.Pharmacol.Exp.Ther_324_179
ESTHER : Anderson_2008_J.Pharmacol.Exp.Ther_324_179
PubMedSearch : Anderson_2008_J.Pharmacol.Exp.Ther_324_179
PubMedID: 17959745

Title : Synthesis and activity of 2-[4-(4-[3H]-2-cyanophenyl)piperazinyl]-N-(2,4,6-[3H]3-3-methylphenyl)acetamide: a selective dopamine D4 receptor agonist and radioligand - Matulenko_2004_Bioorg.Med.Chem.Lett_14_5095
Author(s) : Matulenko MA , Surber B , Fan L , Kolasa T , Nakane M , Terranova MA , Uchic ME , Miller LN , Chang R , Donnelly-Roberts D , Namovic MT , Moreland RB , Brioni JD , Stewart AO
Ref : Bioorganic & Medicinal Chemistry Lett , 14 :5095 , 2004
Abstract : Matulenko_2004_Bioorg.Med.Chem.Lett_14_5095
ESTHER : Matulenko_2004_Bioorg.Med.Chem.Lett_14_5095
PubMedSearch : Matulenko_2004_Bioorg.Med.Chem.Lett_14_5095
PubMedID: 15380206

Title : Characterization of [3H]ABT-418: a novel cholinergic channel ligand - Anderson_1995_J.Pharmacol.Exp.Ther_273_1434
Author(s) : Anderson DJ , Williams M , Pauly JR , Raszkiewicz JL , Campbell JE , Rotert G , Surber B , Thomas SB , Wasicak J , Arneric SP
Ref : Journal of Pharmacology & Experimental Therapeutics , 273 :1434 , 1995
Abstract : Anderson_1995_J.Pharmacol.Exp.Ther_273_1434
ESTHER : Anderson_1995_J.Pharmacol.Exp.Ther_273_1434
PubMedSearch : Anderson_1995_J.Pharmacol.Exp.Ther_273_1434
PubMedID: 7791118